Please Wait.....
Report
Digiceuticals Market Report and Forecast 2025-2034
Market Report I 2025-07-29 I 350 Pages I EMR Inc.
The global digiceuticals market size was valued at USD 6.10 Billion in 2024, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 32.50% during the forecast period of 2025-2034 to achieve a value of USD 101.74 Billion by 2034.
Digiceuticals: Introduction
The use of digital technologies in healthcare has revolutionized patient care. The concept of "Digiceuticals" encompasses a range of tools and services, including mobile applications, wellness assessments, and trackers. These tools are designed to monitor and enhance the effects of medications on the body's physiology, ultimately leading to better patient outcomes.
In today's world, the use of digiceuticals is just as important as the actual medications themselves as they provide valuable insights into the patient's health and help healthcare providers make better-informed decisions.
Global Digiceuticals Market Analysis
The market for digital therapeutics, or digiceuticals, is witnessing rapid growth due to the widespread use of smartphones, mobile apps, and partnerships between technology and pharmaceutical companies. The rise in public awareness of smart health tracking is also contributing to this growth.
Digiceuticals uses modern technologies, such as data analytics, AI, blockchain, and machine learning, to help pharmaceutical companies increase their revenue, cut costs, and improve treatment outcomes, propelling the global digiceuticals market growth further.
For example, automation can speed up drug development and blockchain can protect intellectual property and ensure transparency. Personalized medicine is also a potential use case, using genomic data and patient health records to create targeted drugs at a lower cost.
The growth of the market is further driven by collaborations between pharma and digiceutical companies for various clinical conditions. Regulatory approvals and clearances for digital therapeutic solutions are also increasing, indicating their clinical robustness and acceptance by regulatory bodies. Clinical studies are validating the effectiveness of digital therapeutics, with some showing a reduction in healthcare resource utilization rates for users compared to non-users.
There has been a rise in initiatives, such as suitable reimbursements, which are gaining traction and further increasing people's interest in the market. For instance, DTx companies rely on product adoption and reimbursements from healthcare payers to fully integrate digital therapeutics into mainstream healthcare. Although progress has been slow, the Digital Therapeutics Alliance has recently released a Digital Therapeutics Toolkit to guide the sector's growth and set evidence standards for these innovative solutions.
Global Digiceuticals Market Segmentations
Digiceuticals Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Software
- Devices
Market Breakup by Application
- Mental Health
- Chronic Disease Management
- Medication Adherence
- Others
Market Breakup by End User
- Hospital
- Specialty Clinics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Digiceuticals Market Overview
The market for mHealth applications is experiencing growth due to the rising number of smartphone users. This growth is further fuelled by the increasing prevalence of chronic diseases. According to the CDC's National Center for Chronic Disease Prevention and Health Promotion, 6 out of 10 American adults suffer from a chronic disease, with 4 out of 10 adults having two or more chronic diseases. The increasing prevalence of diabetes is also propelling the need to develop individualized solutions for treating diabetics, adding further growth to the global digiceuticals market share.
The COVID-19 pandemic has had a significant impact on the digital therapeutics market, leading to increased regulatory flexibility and greater access to digital health products. As a result, there has been a surge in demand for convenient and accessible digital health solutions intensifying the growth of the market.
Additionally, regulatory initiatives are expected to drive standardization and research and development in the market in the coming years, further boosting the market growth. An example of this is the Software Pre-Cert Pilot Program, which is part of the FDA's Digital Health Innovation Action Plan, designed to improve oversight of software-based medical devices developed by manufacturers.
The North American market is expected to maintain its leading position over the forecast period. The region is poised to experience a substantial surge in the market due to the implementation of favourable reimbursement scenarios aimed at improving tracking and diagnosis, as well as the increased adoption of digital health products that enhance quality of life.
Key players in the region are actively implementing strategic initiatives, such as launching new products and engaging in mergers and acquisitions, which will further fuel the growth of the market.
Global Digiceuticals Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pear Therapeutics
- Akili Interactive Labs
- Click Therapeutics
- Omada Health
- Happtique
- WellDoc
- Propeller Health (a subsidiary of ResMed)
- Canary Health, Inc.
- Glooko, Inc.
- 2Morrow
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Digiceuticals Market Overview
3.1 Global Digiceuticals Market Historical Value (2018-2024)
3.2 Global Digiceuticals Market Forecast Value (2025-2034)
4 Global Digiceuticals Market Landscape
4.1 Global Digiceuticals: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Digiceuticals: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Digiceuticals Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Digiceuticals Market Segmentation
6.1 Global Digiceuticals Market by Type
6.1.1 Market Overview
6.1.2 Software
6.1.3 Devices
6.2 Global Digiceuticals Market by Application
6.2.1 Market Overview
6.2.2 Mental Health
6.2.3 Chronic Disease Management
6.2.4 Medication Adherence
6.2.5 Others
6.3 Global Digiceuticals Market by End User
6.3.1 Market Overview
6.3.2 Hospital
6.3.3 Specialty Clinics
6.4 Global Digiceuticals Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Digiceuticals Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Digiceuticals Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Digiceuticals Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Digiceuticals Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Digiceuticals Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Pear Therapeutics
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Akili Interactive Labs
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Click Therapeutics
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Omada Health
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Happtique
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 WellDoc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Propeller Health (a subsidiary of ResMed)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Canary Health, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Glooko, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 2Morrow
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security